At 1 year after anti-obesity treatments, there was a significant reduction in BW (average PWL = 5%), BMI and WC, and a significant improvement in glycemia, insulin sensitivity indices, and CRP levels. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.